Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01046 |
| Species: | Homo sapiens |
| Position : | chr8:27610000-27610500 |
| Year: | 2017 |
| Title: | Pseudoexfoliation and Alzheimer's associated CLU risk variant, rs2279590, lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | mantle cell lymphoma |
| PMID: | 28973302 |
| MONDO: | MONDO:0005052 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Rec-1 |
| CVCL ID: | CVCL_1884 |
| Cell Type: | B cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Enhancer perturbation assay |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | CRISPR Knockout, Luciferase Reporter Assay |
| Target gene : | CLU |
| TF name : | HSF1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| HSF1 | Attenuation phase | reactome | 28 |
| HSF1 | HSF1-dependent transactivation | reactome | 34 |
| HSF1 | HSF1 activation | reactome | 31 |
| HSF1 | p73 transcription factor network | pid | 80 |
| HSF1 | Regulation of HSF1-mediated heat shock response | reactome | 82 |
| HSF1 | Hs_DNA_IR-Double_Strand_Breaks_(DSBs)_and_cellular_response_via_ATM_WP3959_91367 | wikipathways | 50 |